Ozdemir Ozcan, Ozbek Zuhtu, Vural Murat, Durmaz Ramazan, Cosan Erhan, Arslantas Ali, Atasoy Metin Ant
Eskisehir Osmangazi University, Department of Neurology, Neurocritical Care, Cerebrovascular Disease, Eskisehir, Turkey.
Eskisehir Osmangazi University, Department of Neurosurgery, Eskisehir, Turkey.
Clin Neurol Neurosurg. 2014 Jul;122:66-9. doi: 10.1016/j.clineuro.2014.04.011. Epub 2014 Apr 26.
The prognosis of malignant middle cerebral artery infarctions (MCA) is poor. The poor prognosis is attributable to the severe cerebral edema that causes a brain herniation and death. Decompressive surgery reduces mortality and may further improve patient outcomes. However, the safety and effectiveness of decompressive surgery in patients who underwent combined intravenous (IV) thrombolysis and endovascular stroke treatment are not certain. Moreover, the evidence on the timing of decompressive surgery is lacking.
The purpose of the open, prospective and non-randomized study was to compare the outcome and complication rates of patients with malignant MCA strokes who underwent early decompressive surgery after combined intravenous thrombolysis and endovascular treatment with those of decompressive surgery patients without prior recanalization treatment strategy. All patients underwent decompressive surgery within 24h of symptom onset.
Thirty patients were included in the study. Twelve of the 30 patients were treated with combined IV thrombolysis and endovascular approach and 18 patients received standard treatment. The proportion of patients with a modified Rankin score ≤3 at the sixth month follow-up was 33% in the standard group and 44% in the combined treatment group (p=0.712). Mortality, and major and minor complications including symptomatic intracerebral hemorrhage after decompressive surgery did not differ between the two groups (p>0.05).
Early decompressive surgery can be safely performed in patients who received combined IV thrombolysis and endovascular treatment and there was no difference in outcome of these patients compared with patients who did receive the standard medical treatment before early decompressive surgery.
恶性大脑中动脉梗死(MCA)的预后较差。预后不良归因于严重的脑水肿,可导致脑疝和死亡。减压手术可降低死亡率,并可能进一步改善患者预后。然而,对于接受静脉溶栓和血管内卒中治疗联合治疗的患者,减压手术的安全性和有效性尚不确定。此外,关于减压手术时机的证据也很缺乏。
这项开放、前瞻性、非随机研究的目的是比较接受静脉溶栓和血管内治疗后早期减压手术的恶性MCA卒中患者与未采用先前再通治疗策略的减压手术患者的结局和并发症发生率。所有患者均在症状发作后24小时内接受减压手术。
30例患者纳入研究。30例患者中,12例接受静脉溶栓和血管内联合治疗,18例接受标准治疗。标准治疗组在6个月随访时改良Rankin评分≤3的患者比例为33%,联合治疗组为44%(p=0.712)。两组之间的死亡率以及包括减压手术后症状性脑出血在内的主要和次要并发症无差异(p>0.05)。
对于接受静脉溶栓和血管内联合治疗的患者,可以安全地进行早期减压手术,与早期减压手术前接受标准药物治疗的患者相比,这些患者的结局没有差异。